Jiangxi Kelun Pharmaceutical Co., Ltd. and Hubei Yinuokang Medical Technology Co., Ltd. agreed to acquire 49% stake in Wuhan Quanruinuo Pharmaceutical Technology Co., Ltd. from Tibet Duo Rui Pharmaceutical Co.,Ltd. (SZSE:301075) for CNY 0 on January 19, 2024. As of September 30, 2023, in Wuhan Quanruinuo Pharmaceutical Technology Co., Ltd. generated total assets of CNY 3.1 million and net assets of CNY 3.1 million.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
16.89 CNY | -4.68% | -8.65% | -36.67% |
1st Jan change | Capi. | |
---|---|---|
-36.67% | 184M | |
+42.83% | 750B | |
+34.11% | 606B | |
-5.70% | 356B | |
+18.06% | 326B | |
+4.63% | 286B | |
+17.85% | 246B | |
+11.01% | 213B | |
-3.07% | 213B | |
+2.43% | 167B |
- Stock Market
- Equities
- 301075 Stock
- News Tibet Duo Rui Pharmaceutical Co., Ltd.
- Jiangxi Kelun Pharmaceutical Co., Ltd. and Hubei Yinuokang Medical Technology Co., Ltd. agreed to acquire 49% stake in Wuhan Quanruinuo Pharmaceutical Technology Co., Ltd. from Tibet Duo Rui Pharmaceutical Co.,Ltd. for CNY 0.